Immunization

GSK and MVI Announce Promising Malaria Vaccine Trial Results

Last week GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies and the PATH Malaria Vaccine Intiative (MVI), announced that the world may be closer to a malaria vaccine than once thought.  Working together, MVI and GSK announced results from a large scale trail in Africa testing the RTS,S vaccine which demonstrated…

Read More

Potential UNEP Treaty Language Could Impact Vaccines

This is a guest blog by Erin Fry, Government Affairs Officer of PATH. The United Nations Environment Programme (UNEP) is supporting the development of a treaty on mercury which may include language that impacts access to vaccines in poor countries. Thiomersal (which also goes by the name thimerosal) is a key preservative that contains small amounts of…

Read More

We Started! The First Child in Sudan to Receive a Rotavirus Vaccine

This is a guest blog by Dr. Amani Abdelmoniem Mustafa, manager of the Expanded Programme on Immunization for Sudan. KHARTOUM, Sudan — The day that we were waiting for arrived. The children of Sudan have long suffered terrible, sometimes deadly, diarrhea caused by rotavirus. Fortunately, there is a vaccine that can save our children from so much…

Read More

FC Barcelona's New Goal

Bill Gates on the soccer team’s new partnership with the Gates Foundation in the fight to end polio Contrary to popular belief, I don’t spend a whole lot of time following soccer. But as I have travelled around the world to better understand global development and health, I’ve learned that soccer is truly universal. No…

Read More

Amani: One of the Vaccine Delivery Heroes

This is a guest blog by Dr. John Wecker, the director of Vaccine Access and Delivery at PATH. Resourceful, brave, committed — and perhaps a little addicted — that’s the kind of person it takes to ensure that vaccines reach children in the poorest countries of the world. People like Amani Abdelmoniem Mustafa, the manager of…

Read More

Vaccines: Saving Lives and Dollars

This is a guest blog by Erin Fry, a government affairs officer at PATH. Last week, I attended a briefing on Capitol Hill titled “Making the Case for Cost-Effectiveness of Vaccines for Global Health” sponsored by Research!America, the Global Health Council, and PATH. The briefing focused on how vaccines not only save lives, but dollars, too. Panelists Marc LaForce of…

Read More

Virus-sharing: A Victory for Global Health Diplomacy

This guest blog is written by Rachel Irwin, a PhD candidate at the London School of Hygiene and Tropical Medicine and a member of the Global Health Council delegation to the World Health Assembly. GENEVA — For over 50 years, countries have shared samples of their viruses via the World Health Organization (WHO)’s Global Influenza…

Read More

Making This "The Decade of Vaccines"

This guest blog was written by Helen Evans, interim chief executive of the GAVI Alliance. GENEVA — I am Helen Evans, the interim chief executive of the Global Alliance for Vaccines and Immunisation, and our mission is to save children’s lives and protect people’s health by increasing access to immunisation in poor countries. Right now…

Read More

Q & A With Dr. Roma Chilengi, Kemri

John Donnelly interviews Dr. Roma Chilengi, head of clinical trials at the KEMRI-Wellcome Trust Research Programme in Kenya. Dr. Roma Chilengi was the head of clinical trials at the Kenya Medical Research Institute(KEMRI)-Wellcome Trust Research Programme in Kilifi, Kenya, from 2008 until April 2011. While he worked on several vaccine trials, Chilengi specialized in malaria vaccine…

Read More